About Qbic Fund
Qbic Fund is a venture capital firm founded in 2012. It is primarily based out of Ghent, Belgium. As of Jul 2026, Qbic Fund is an active investor, having invested in 48 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in Belgium based startups. Its investments are spread across a wide range of sectors from High Tech to Life Sciences and HealthTech. Most recently it participated in the $***** Seed round of Sightera Biosciences Overall, Qbic Fund portfolio has seen 1 IPO and 9 acquisitions including key companies like Biotalys, Sentiance and Unifly. A lot of funds co-invest with Qbic Fund, with names like PMV sharing a substantial percentage of its portfolio. Qbic Fund has team of 11 people including 5 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio IPOs
Portfolio Acquisitions
Deals in last 12 months
Qbic Fund's List of Top Investments
Qbic Fund has a portfolio of 48 companies. Their most notable investments are in VoxelSensors and Calltic.Their portfolio spans across Belgium, Netherlands and United States. They have invested in High Tech, Life Sciences, HealthTech and 19 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Qbic Fund:1. Biotalys
Agritech company pioneering protein-based biocontrol solutions for sustainable and safe food. They develop a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Their groundbreaking technology platform develops a unique pipeline of effective and safe products with novel modes of action, addressing key crop pests and diseases across the whole food value chain. They transform crop protection with their unique protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Their products offer farmers reliable and safe tools to prevent crop loss while extending post-harvest protection and reducing food waste. They focus on safer food and a better planet through innovative agricultural solutions.
Key facts about Biotalys
- Founded Year: 2013
- Location: Ghent (Belgium)
- Annual Revenue: €1M - €10M as on Dec 31, 2018
- Stage: Public
- Total Funding till date: $53.6M
- Employee Count: 52 as on Jun 30, 2026
- Investors: Novalis LifeSciences, Gates and 11 Others
- Latest Funding Round: Post IPO, Oct 16, 2024, $*****
- Highlight: Public
2. Sentiance
Provider of on-device AI motion insights for improved road safety. This company develops AI technology that processes mobile sensor data to generate driving, mobility, and lifestyle insights. The technology is designed for cost-efficiency, privacy, and scalability, enabling solutions for various sectors including motor insurance, transportation authorities, and automotive manufacturers. The platform helps improve driver and rider safety, reduce fraud, and accelerate claims processing. It offers features for hyper-personalization and contributes to sustainable mobility initiatives. The technology prioritizes data privacy through edge computing, ensuring data remains on the user's device. The company adheres to strict security and privacy standards, including GDPR compliance and ISO certifications.
Key facts about Sentiance
- Founded Year: 2012
- Location: Antwerp (Belgium)
- Stage: Acquired
- Total Funding till date: $28M
- Employee Count: 41 as on Jun 30, 2026
- Investors: Samsung Catalyst Fund, Curiosity and 13 Others
- Latest Funding Round: Series C, Mar 04, 2020, $*****
- Highlight: Acquired
3. Unifly
Provider of a platform for drone traffic management. The products include BLIP, unmanned traffic management (UTM), and a supervisor portal. It provides drone tracking and e-Identification solutions, UTM is a platform for integrating drones into the airspace, and the supervisor portal provides support for ANSPs and authorities to survive and regulate airspace.
Key facts about Unifly
4. VoxelSensors
Developer of spatial and empathic computing technology using single photon sensors. This technology enables the development of AI agents that understand user context and environment through real-time acquisition of human contextual data. The company's low-bandwidth, low-power solution is optimized for wearable devices, focusing on attention-based data gathering to capture only relevant information. This approach allows AI assistants to anticipate user needs, distinguish between casual and genuine interest, and identify visual focus points. The core technology involves a combination of advanced sensors and an attention-triggered data processing system.
Key facts about VoxelSensors
- Founded Year: 2020
- Location: Brussels (Belgium)
- Stage: Seed
- Total Funding till date: $10.3M
- Employee Count: 25 as on Jun 30, 2026
- Investors: Capricorn Partners, Qbic Fund and 3 Others
- Latest Funding Round: Seed, Jan 30, 2024, $*****
- Highlight: Editors' Pick
5. MRM Health
Developer of optimized consortia therapeutics targeting inflammatory, CNS, and metabolic diseases. The company utilizes a proprietary platform to design and manufacture microbial therapeutics. Optimized consortia are developed through a bioinformatics-guided discovery engine. The company focuses on creating therapeutics with disease-modifying potential. Clinical programs include inflammatory bowel diseases, with preclinical programs in CNS and metabolic diseases. The company features end-to-end development capabilities, from discovery to clinical development.
Key facts about MRM Health
Qbic Fund's Year-on-Year Investment Trends
Qbic Fund has invested in 48 companies over the last 13 years, with an average of 3 new investments annually in the last 10 years. In 2025, it made 5 investments, while as of Jul 2026, it has made 2 investments in this year. Its most recent first time investment was in Sightera Biosciences and most recent follow-on round was in eyeo.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 3 | 2 | 5 |
2024 | 2 | 4 | 6 |
2023 | 2 | 1 | 3 |
2022 | 7 | 2 | 9 |
2021 | 3 | 0 | 3 |
2020 | 3 | 1 | 4 |
2019 | 1 | 2 | 3 |
2018 | 2 | 1 | 3 |
2017 | 3 | 2 | 5 |
Qbic Fund's Investments by Stage
Qbic Fund has made 20 investments in Seed stage with an average round size of $3.87M, 17 investments in Series A stage with an average round size of $7.04M and 4 investments in Series B stage with an average round size of $8.98M.Stage of entry | No. of Investments |
|---|---|
Seed | 20 |
Series A | 17 |
Series B | 4 |
Note: We have considered here, only first round of investments
Qbic Fund's Investments by Sector
Qbic Fund has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, HealthTech and Semiconductors. Notably, it has invested in 40 Enterprise (B2B) companies, 40 Tech companies, 17 Software companies and at least 15 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 17 |
High Tech | 16 |
Enterprise Applications | 10 |
HealthTech | 8 |
Semiconductors | 5 |
Others | 47 |
Note: We have considered here, only first round of investments
Qbic Fund's Investments by Geography
Qbic Fund has made most investments in Belgium (37), followed by Netherlands where it has made 2 investments.Country | No. of Investments |
|---|---|
Belgium | 37 |
Netherlands | 2 |
United States | 2 |
Note: We have considered here, only first round of investments
Qbic Fund's recent investments
Qbic Fund has made 2 investments in 2026 so far - Sightera Biosciences and eyeo.Here are the most recent investments by Qbic Fund:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 17, 2026 | Belgium | Seed | 4660 | [+1] | |
May 11, 2026 | Netherlands | Series A | 2359 | ||
Dec 02, 2025 | Belgium | Seed | 9819 | [+2] | |
Sep 04, 2025 | Belgium | Series B | 2692 | [+6] | |
May 07, 2025 | Netherlands | Seed | 1914 | [+3] |
IPOs and Publicly Listed companies in Qbic Fund's Portfolio
1 of Qbic Fund's portfolio company became public - Biotalys. It got listed on the Euronext Exchange (Euronext), in Jul 2021 at marketcap of $267MHere are Qbic Fund's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 02, 2021 | - | - | 1267 |
Acquired companies in Qbic Fund's Portfolio
9 companies from Qbic Fund's portfolio have been acquired. The most recent acquisition was Unifly in Aug 2023 by Terra Drone Corp for $*****.Here are Qbic Fund's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 22, 2023 | Aug 2015 | Seed | 9520 | |
Dec 14, 2021 | Oct 06, 2014 | Series A | 9134 | |
Nov 19, 2021 | Jan 07, 2016 | Seed | 6525 | |
Nov 01, 2021 | Jun 30, 2014 | Seed | 4797 | |
Feb 15, 2021 | Nov 17, 2015 | Series B | 2828 |
Team profile of Qbic Fund
Qbic Fund has a team of 11 members including 5 Partners located in Belgium. Qbic Fund's team sits on the board of 1 company.Here is a list of top team members in Qbic Fund:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Ghent | - | ||
Partner | Ghent | - | ||
Partner | Ghent | - | ||
Partner | Leuven | |||
Partner | Ghent | - |
Co-investors of Qbic Fund
Over the past 13 years, 146 investors have co-invested in Qbic Fund's portfolio companies. This includes funds and angels.
- Invested before Qbic Fund: imec.istart, Europa and 21 others have invested in rounds before Qbic Fund. There are 5 companies where imec.istart has invested before Qbic Fund and 2 companies where Europa has invested before Qbic Fund.
- Top Co-investors of Qbic Fund: 66 investors entered a company along with Qbic Fund. These include investors like PMV (7 companies).
- Invested after Qbic Fund: A total of 57 investors have invested in Qbic Fund's portfolio after their investments. Top Investors include Europa (6 companies), SFPIM (4 companies) and SFPI (3 companies).
Recent News related to Qbic Fund
•
Sightera Biosciences Raises €3 Million Pre-Seed to Enhance AI Drug Discovery PlatformStartup Rise EU•Jul 17, 2026•Sightera Biosciences, Entourage, Qbic Fund, Anacura and 1 other
•
eyeo Secures €40 Million to Enhance Imaging Technology and Sensor PerformanceStartup Rise EU•May 11, 2026•Innovation Industries, eyeo, HTGF, Europa and 4 others
•
MRM Health Raises €55 Million Series B to Advance Microbiome Biotherapeutic PipelineBusiness Wire•Sep 04, 2025•MRM Health, Biocodex, B&B Italia, Ackermans and 8 others
•
Biocodex invests up to 30 million euros in partnership with MRM Health.MyPharma Editions•Sep 04, 2025•MRM Health, Biocodex, Ackermans & van Haaren, SFPIM and 4 others
•
eyeo Secures €15 Million Seed Funding to Revolutionize Camera Perceptionoptics.org•May 08, 2025•eyeo, Imec, imec.xpand, Invest-NL and 2 others
•
imec spin-off eyeo raises €15 million to give cameras perfect eyesightEvertiq•May 08, 2025•eyeo, imec.xpand, Invest-NL, Qbic Fund and 2 others
•
Eyeo secures €15M seed round to focus on ultra-compact high-resolution imaging
Tech Funding News•May 07, 2025•eyeo, imec.xpand, Invest-NL, Gov.nl and 2 others
•
Antwerp’s Aloxy raises €7.4M to build IIoT solutions for the energy and chemical industrySilicon Canals•Mar 11, 2025•Aloxy, Dow Chemical Company, Emerson, Qbic Fund and 7 others
•
Pleevi raises €1 million for AI-powered Electric Vehicle charging across EuropeEU-Startups•Jan 30, 2025•Pleevi, Angelwise, Seeder Fund, Noshaq and 1 other
•
Swave Photonics Secures €27M Series A to Advance AR Holographic Display TechAuganix•Jan 13, 2025•Luminate, Imec, PMV Electric, Qbic Fund and 9 others
